What I like about BIOC:
1. Higher lows on the daily
2. RSI crossed above the 50
3. MACD still bullish
4. Range to 50ma within reach.
5. Break above 50ma could fill gap to .49
6. MA's in alignment.
7. Showed up on EOD scan - 87% chance of running tomorrow.
The stock is a big % Gainer , it will be in the watchlist of many traders this week and might be going up after its apocalypse
The price now is in a rang between 1.80 and 1.40
If it will break The 1.80 , we have a great probability to go long to the 3.37 ( Last Big top ) forming perhaps a double top for another colapse ( Or not )
If it will break the 1.40 ,...
Biocept has the best-in-breed liquid biopsy testing in the Immuno-Oncology space. Market cap is 70 million, but it's going to be several billion in a few years if they don't get bought out first.
Revenue in the second quarter ended 6/30/2016 increased 8 fold to 663,000 from 77,000 last year. This revenue only included half of June for their commerical launch of...
The pennant consolidation is about over, it is ready to break out and make the next leg of its upward journey starting out with a measured move. Since it is so close to the apex of the pennant with a doji, anyone short should consider covering immediately.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
NASDAQ:BIOC
